Featured Content
As clinical trial decentralization gains traction, there is one bottleneck limiting equitable access: inconsistent patient identification. Becker’s spoke to 14…
As clinical trial decentralization gains traction, there is one bottleneck limiting equitable access: inconsistent patient identification. Becker’s spoke to 14…